Oral contraceptives—possible mediation of side effects via an estrogen receptor in liver
- 1 January 1978
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (22) , 2571-2575
- https://doi.org/10.1016/0006-2952(78)90329-5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HD X2-W)
This publication has 35 references indexed in Scilit:
- Effects of Oral Contraceptives on the Gallbladder Bile of Normal WomenNew England Journal of Medicine, 1976
- Myocardial infarction in young women with special reference to oral contraceptive practice.BMJ, 1975
- Surgically Confirmed Gallbladder Disease, Venous Thromboembolism, and Breast Tumors in Relation to Postmenopausal Estrogen TherapyNew England Journal of Medicine, 1974
- The Coronary Drug ProjectJAMA, 1973
- ANTITHROMBIN III AND THE ŒSTROGEN CONTENT OF COMBINED ŒSTRO-PROGESTAGEN CONTRACEPTIVESThe Lancet, 1972
- Hormonal contraception and thromboembolic disease: Effects of the oral contraceptives on hemostatic mechanisms: A review of the literatureJournal of Chronic Diseases, 1971
- EFFECTS OF AN ORAL CONTRACEPTIVE AGENT ON PLASMA LIPIDS, PLASMA LIPOPROTEINS, THE INTRAVENOUS FAT TOLERANCE AND THE POST‐HEPARIN LIPOPROTEIN LIPASE ACTIVITYActa Medica Scandinavica, 1971
- Hypertension, Oral Contraceptive Agents, and Conjugated EstrogensAnnals of Internal Medicine, 1971
- Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostateCancer, 1970
- Serum Luteinizing and Follicle Stimulating Hormone Levels During Sequential and Nonsequential Contraceptive Treatment of Eugonadal WomenJournal of Clinical Endocrinology & Metabolism, 1969